Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How RheumPAC Is Supporting You in Uncertain Times

From the College  |  February 11, 2025

The ACR has been closely monitoring the recent executive orders and other government actions, and we recognize the uncertainty and concern these policies raise. As the new administration continues to enact policies that impact you and the care you provide to your patients, RheumPAC is working to inform key lawmakers of the downstream effects of these unilateral actions. A full 100% of every contribution to RheumPAC goes directly to supporting our efforts—consider making an investment today.

Keep reading to find answers to some commonly asked questions about RheumPAC and its important role in the ACR’s advocacy efforts. You can also hear from your colleagues about why they invest in RheumPAC.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

What is a political action committee (PAC)?

A political action committee is a group or legal entity formed to raise and contribute money to the campaigns of candidates whom they support. PACs are highly regulated by the Federal Election Commission, and RheumPAC is required to file publicly available quarterly reports that detail all contributions and disbursements. These reports are available for download.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What is RheumPAC and why do we need it?

RheumPAC is the ACR’s nonpartisan PAC, which works to elect and support pro‐rheumatology candidates. It is the only federal PAC dedicated to the interests of the rheumatology profession. RheumPAC was formed in 2007 and creates opportunities to educate and develop relationships with members of Congress, as well as support champions for our issues and our message. It is the financial vehicle through which ACR and ARP members can support Congressional candidates who share our commitment to rheumatology. In the current political climate, issues impacting ACR members and their patients are evolving daily, and it is critical that our positions are well-represented on Capitol Hill.

What makes a lawmaker an ACR congressional champion, and who receives financial support from RheumPAC?

RheumPAC is bipartisan and determines candidates’ eligibility for a contribution based on their past support for policies that directly impact rheumatology or their ability to further our goals in their position in Congress. For example, RheumPAC-supported lawmakers may introduce or co-sponsor ACR-endorsed legislation or serve on key committees that have jurisdiction over the ACR’s priority issues. ACR staff exercise discretion to ensure that your funds are used responsibly and effectively. In fact, 95% of RheumPAC-supported candidates won re-election in 2024.

Candidates are recommended for support by ACR/ARP members and our advocacy staff. The RheumPAC committee reviews these recommendations and has final approval of the list of supported candidates. All U.S. ACR and ARP members are welcome to suggest candidates for support.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:RheumPAC

Related Articles

    PAC a Punch on Capitol Hill

    May 1, 2007

    New political action committee will be a voice for rheumatology

    New ACR/ARP Committee Members Are Ready to Work

    January 16, 2020

    Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences